Revance Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Cash & Equivalents	-	261.13	175.49	35.16	13.65	222.53	Upgrade
Short-Term Investments	-	-	-	-	5.97	-	Upgrade
Cash & Short-Term Investments	261.13	261.13	175.49	35.16	19.62	222.53	Upgrade
Cash Growth	48.81%	48.81%	399.18%	79.16%	-91.18%	39.79%	Upgrade
Accounts Receivable	-	3.08	3.88	1.49	3.95	3.66	Upgrade
Receivables	-	39.74	28.31	20.51	91.71	10.89	Upgrade
Inventory	-	6,982	4,331	2,938	2,101	1,966	Upgrade
Prepaid Expenses	-	66.71	74.96	76.63	-	-	Upgrade
Other Current Assets	-	1,783	1,252	548.98	150.4	381.22	Upgrade
Total Current Assets	-	9,132	5,862	3,619	2,363	2,581	Upgrade
Property, Plant & Equipment	-	2,744	2,531	1,910	1,503	1,301	Upgrade
Long-Term Investments	-	165.33	205.96	532.36	268.69	1.25	Upgrade
Long-Term Deferred Tax Assets	-	77.44	63.64	70.66	58.12	-	Upgrade
Long-Term Deferred Charges	-	-	-	-	-	0.77	Upgrade
Other Long-Term Assets	-	116.1	91.66	43.31	18.52	17.65	Upgrade
Total Assets	-	12,234	8,754	6,176	4,212	3,901	Upgrade
Accounts Payable	-	1,487	619.48	536.1	575.71	1,333	Upgrade
Accrued Expenses	-	50.18	53.69	37.43	17.73	13.7	Upgrade
Short-Term Debt	-	2,784	1,229	2,402	1,402	739.24	Upgrade
Current Portion of Long-Term Debt	-	-	23.84	115.14	24.84	15.36	Upgrade
Current Portion of Leases	-	209.73	143.83	109.57	77	58.91	Upgrade
Current Income Taxes Payable	-	20.03	-	27.38	6.34	81.79	Upgrade
Other Current Liabilities	-	36.75	27.02	32.74	6.86	13.68	Upgrade
Total Current Liabilities	-	4,587	2,097	3,261	2,111	2,256	Upgrade
Long-Term Debt	-	-	-	188.23	137.83	87.37	Upgrade
Long-Term Leases	-	1,811	1,790	1,364	1,176	1,076	Upgrade
Long-Term Deferred Tax Liabilities	-	-	-	-	-	-13.35	Upgrade
Total Liabilities	-	6,398	3,887	4,813	3,425	3,407	Upgrade
Common Stock	-	128.66	128.19	120.29	120.29	120.29	Upgrade
Additional Paid-In Capital	-	2,806	2,801	-	-	-	Upgrade
Retained Earnings	-	2,790	1,851	1,236	666.63	373.96	Upgrade
Comprehensive Income & Other	-	112.05	86.7	6.7	-	-	Upgrade
Shareholders' Equity	5,837	5,837	4,867	1,363	786.91	494.25	Upgrade
Total Liabilities & Equity	-	12,234	8,754	6,176	4,212	3,901	Upgrade
Total Debt	4,804	4,804	3,186	4,179	2,818	1,977	Upgrade
Net Cash (Debt)	-4,543	-4,543	-3,011	-4,144	-2,799	-1,755	Upgrade
Net Cash Per Share	-35.17	-35.15	-24.68	-34.45	-23.27	-14.59	Upgrade
Filing Date Shares Outstanding	128.58	128.66	128.19	120.29	120.29	120.29	Upgrade
Total Common Shares Outstanding	128.58	128.66	128.19	120.29	120.29	120.29	Upgrade
Working Capital	-	4,545	3,765	358.62	252.36	324.58	Upgrade
Book Value Per Share	45.36	45.36	37.97	11.33	6.54	4.11	Upgrade
Tangible Book Value	5,837	5,837	4,867	1,363	786.91	494.25	Upgrade
Tangible Book Value Per Share	45.36	45.36	37.97	11.33	6.54	4.11	Upgrade
Machinery	-	1,273	977.79	706.06	521.94	341.31	Upgrade
Construction In Progress	-	62.51	89.06	80.54	-	-	Upgrade

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.